RAD242 - MR guided Freehand-Biopsy of suspect Lesions in a 3T High Field MR-System

RAD242 - MR guided Freehand-Biopsy of suspect Lesions in a 3T High Field MR-System - Prostata-Punktion 3T MRT

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00010958

Enrollment

Registered

2016-08-26

Start date

2015-11-02

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C61

Interventions

Group 1: First, a multi-parametric imaging of the prostate with the use of endorectal coil in accordance with the routine protocol of MR prostate diagnostics. In case of suspicious lesion in the prost

Eligibility

Sex/Gender

Male

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients that are suspected to have prostate carcinoma and either underwent negative TRUS-Biopsy or rejected TRUS-Biopsy

Exclusion criteria

Exclusion criteria: Contraindactions for MRI (3T) Contraindications for percutaneous interventions (insufficient hämostasis, and others) Patients with a high risk of adverse events (e.g. very reduced general condition) Rejection of MR-guided Prostate biopsy PSA>100

Design outcomes

Primary

Measure	Time frame
establishment of a simple and safe intervention protocol for the MR guided pararectal freehand biopsy of prostate lesions in a 3.0 Tesla high field MRT	—

Secondary

Measure	Time frame
Comparison of sensitivity and specifity of diagnostic MRI using surface coil vs. endorectal coil. The result of MR-guided biopsy is used as gold standard.	—

Countries

Germany

Contacts

Public ContactJens Ricke

Klinik für Radiologie und NuklearmedizinUniversität Magdeburg

jens.ricke@med.ovgu.de+391-6713030

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026